Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis
NCT03452540
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class
Stopped
Company Decision
Conditions
Severe Acute Decompensated Alcoholic Hepatitis
Interventions
DRUG:
1000mg DS102 (BID)
Sponsor
Afimmune